TY - JOUR
T1 - The effect of chronic phenytoin administration on single prolonged stress induced extinction retention deficits and glucocorticoid upregulation in the rat medial prefrontal cortex
AU - George, Sophie A.
AU - Rodriguez-Santiago, Mariana
AU - Riley, John
AU - Rodriguez, Elizabeth
AU - Liberzon, Israel
N1 - Funding Information:
The research in this report was funded by a Department of Defense grant W81XWH-08-1-0661 awarded to Israel Liberzon. We would like to thank Dayan Knox, Chieh Chen, Nirmala Rajaram, Lan Xiao, Heidi Winklemann, and Emma Andrews for their help in conducting the experiments described in this manuscript.
Publisher Copyright:
© Springer-Verlag 2014.
PY - 2015/1
Y1 - 2015/1
N2 - Rationale: Post-traumatic stress disorder (PTSD) is a chronic, debilitating disorder. Only two pharmacological agents are approved for PTSD treatment, and they often do not address the full range of symptoms nor are they equally effective in all cases. Animal models of PTSD are critical for understanding the neurobiology involved and for identification of novel therapeutic targets. Using the rodent PTSD model, single prolonged stress (SPS), we have implicated aberrant excitatory neural transmission and glucocorticoid receptor (GR) up-regulation in the medial prefrontal cortex (mPFC) and hippocampus (HPC) in fear memory abnormalities associated with PTSD. Objective: The objective of this study is to examine the potential protective effect of antiepileptic phenytoin (PHE) administration on SPS-induced extinction retention deficits and GR expression. Methods: Forty-eight SPS-treated male Sprague Dawley rats or controls were administered PHE (40, 20 mg/kg, vehicle) for 7 days following SPS stressors; then, fear conditioning, extinction, and extinction retention were tested. Results: Fear conditioning and extinction were unaffected by SPS or PHE, but SPS impaired extinction retention, and both doses of PHE rescued this impairment. Similarly, SPS increased GR expression in the mPFC and dorsal HPC, and PHE prevented SPS-induced GR upregulation in the mPFC. Conclusions: These data demonstrate that PHE administration can prevent the development of extinction retention deficits and upregulation of GR. PHE exerts inhibitory effects on voltage-gated sodium channels and decreases excitatory neural transmission via glutamate antagonism. If glutamate hyperactivity in the days following SPS contributes to SPS-induced deficits, then these data may suggest that the glutamatergic system constitutes a target for secondary prevention.
AB - Rationale: Post-traumatic stress disorder (PTSD) is a chronic, debilitating disorder. Only two pharmacological agents are approved for PTSD treatment, and they often do not address the full range of symptoms nor are they equally effective in all cases. Animal models of PTSD are critical for understanding the neurobiology involved and for identification of novel therapeutic targets. Using the rodent PTSD model, single prolonged stress (SPS), we have implicated aberrant excitatory neural transmission and glucocorticoid receptor (GR) up-regulation in the medial prefrontal cortex (mPFC) and hippocampus (HPC) in fear memory abnormalities associated with PTSD. Objective: The objective of this study is to examine the potential protective effect of antiepileptic phenytoin (PHE) administration on SPS-induced extinction retention deficits and GR expression. Methods: Forty-eight SPS-treated male Sprague Dawley rats or controls were administered PHE (40, 20 mg/kg, vehicle) for 7 days following SPS stressors; then, fear conditioning, extinction, and extinction retention were tested. Results: Fear conditioning and extinction were unaffected by SPS or PHE, but SPS impaired extinction retention, and both doses of PHE rescued this impairment. Similarly, SPS increased GR expression in the mPFC and dorsal HPC, and PHE prevented SPS-induced GR upregulation in the mPFC. Conclusions: These data demonstrate that PHE administration can prevent the development of extinction retention deficits and upregulation of GR. PHE exerts inhibitory effects on voltage-gated sodium channels and decreases excitatory neural transmission via glutamate antagonism. If glutamate hyperactivity in the days following SPS contributes to SPS-induced deficits, then these data may suggest that the glutamatergic system constitutes a target for secondary prevention.
KW - Anticonvulsant
KW - Conditioned fear
KW - Glutamate
KW - Hypothalamic-pituitary-adrenal axis
KW - Post-traumatic stress disorder
KW - Secondary prevention
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=84939876081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939876081&partnerID=8YFLogxK
U2 - 10.1007/s00213-014-3635-x
DO - 10.1007/s00213-014-3635-x
M3 - Article
C2 - 24879497
AN - SCOPUS:84939876081
SN - 0033-3158
VL - 232
SP - 47
EP - 56
JO - Psychopharmacology
JF - Psychopharmacology
IS - 1
ER -